Product NDC: | 49288-0182 |
Proprietary Name: | Mixture of Standardized Mites |
Non Proprietary Name: | Mixture of Standardized Mites |
Active Ingredient(s): | 5000; 5000 [AU]/mL; [AU]/mL & nbsp; Mixture of Standardized Mites |
Administration Route(s): | INTRADERMAL; SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 49288-0182 |
Labeler Name: | Antigen Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA102225 |
Marketing Category: | BLA |
Start Marketing Date: | 19911022 |
Package NDC: | 49288-0182-2 |
Package Description: | 5 mL in 1 VIAL, MULTI-DOSE (49288-0182-2) |
NDC Code | 49288-0182-2 |
Proprietary Name | Mixture of Standardized Mites |
Package Description | 5 mL in 1 VIAL, MULTI-DOSE (49288-0182-2) |
Product NDC | 49288-0182 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Mixture of Standardized Mites |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRADERMAL; SUBCUTANEOUS |
Start Marketing Date | 19911022 |
Marketing Category Name | BLA |
Labeler Name | Antigen Laboratories, Inc. |
Substance Name | DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS |
Strength Number | 5000; 5000 |
Strength Unit | [AU]/mL; [AU]/mL |
Pharmaceutical Classes | Standardized Insect Protein Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Antigens, Dermatophagoides [Chemical/Ingredient],Insect Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Insect Protein Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Antigens, Dermatophagoides [Chemical/Ingredient],Insect Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient] |